| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/04/2003 | US20030166565 CD antigens; for regulating inflammation; nuclear magnetic resonance; drug screening |
| 09/04/2003 | US20030166558 Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid beta, prion protein, amylin, alpha-synuclein, or polyglutamine repeats for induction of an immune response thereto |
| 09/04/2003 | US20030166556 Immunoregulator |
| 09/04/2003 | US20030166542 Systemic immune response induced by mucosal administration of lipid-tailed polypeptides without adjuvant |
| 09/04/2003 | US20030166538 Isolated inflammation-related gene, the protein molecule encoded by the gene, and the use of the gene in diagnosis and treatment of inflammatory conditions. |
| 09/04/2003 | US20030166537 Use of a gial cell line-derived growth factor (GDNF) or a functionally active derivative or part thereof and/or an agonist which substitutes the functional activity of GDNF, and/ or a nucleic acid containing at least a nucleotide |
| 09/04/2003 | US20030166530 Conjugate heat shock protein-binding peptides |
| 09/04/2003 | US20030166526 Novel gene (designated 158P1H4) and its encoded protein are described. While 158P1H4 exhibits tissue specific expression in normal adult tissue, it is aberrantly expressed in multiple cancers including set forth in Table 1. Consequently, 158P1H4 |
| 09/04/2003 | US20030166524 Therapeutic uses of IL-1 receptor antagonist |
| 09/04/2003 | US20030166277 Targeted vaccine delivery systems |
| 09/04/2003 | US20030166254 Moving promoter distal gene toward a wild-type 3' gene; gene mapping, genetic engineering; an attenuated virus useful for a vaccine |
| 09/04/2003 | US20030166238 Recombinant toxin fragments |
| 09/04/2003 | US20030166228 Anti-interferon-alpha antibodies |
| 09/04/2003 | US20030166219 Mitogen-activated protein/extracellular signal-regulated kinases (MAP/ERK) |
| 09/04/2003 | US20030166168 Variant varicella-zoster viruses and methods of use |
| 09/04/2003 | US20030166150 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 09/04/2003 | US20030166140 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide polyadenylation sequence all |
| 09/04/2003 | US20030166097 Comprises nucleotide sequences coding membrane proteins for use diagnosing, treating and preventing autoimmune, inflammatory, viral, infectious and cancer diseases |
| 09/04/2003 | US20030166073 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 09/04/2003 | US20030166057 Method and apparatus for the production of soluble MHC antigens and uses thereof |
| 09/04/2003 | US20030166044 Novel proteins |
| 09/04/2003 | US20030166041 Nucleotide sequences coding tim mitochondrial protein (TRP) which comprises zinc finger membrane protein for treating, diagnosing and preventing cancer and neurodegenerative diseases |
| 09/04/2003 | US20030166029 Obtaining an inhibitor of antibody-mediated lipid oxidation; drug screening; hemolysis; anticholesterol agents; cardiovascular disorder therapy |
| 09/04/2003 | US20030166024 Nucleotide sequences coding monoclonal antibody for the prevention, treatment and diagnosis of viral, inflammatory and tumor diseases; gene therapy |
| 09/04/2003 | US20030166022 Polypeptide for detecting and treating cancer; genetic vaccine |
| 09/04/2003 | US20030165995 Novel antibodies and ligands for "Bonzo" chemokine receptor |
| 09/04/2003 | US20030165988 High throughput generation of human monoclonal antibody against peptide fragments derived from membrane proteins |
| 09/04/2003 | US20030165950 Inducing the production of antibodies, in vivo, that specifically bind to nicotine. These conjugates comprise a nicotine hapten conjugated to an immunogenic carrier protein. The novel conjugates preserve the chirality of nicotine in |
| 09/04/2003 | US20030165930 Polynucleotides encoding for polymorphic isoforms of the pthrp protein, the encoded proteins and their therapeutic applications thereof |
| 09/04/2003 | US20030165909 Screening cell sample for presence of lung nucleotide sequences (LS170) for diagnosing, classifying, monitoring, prognosing, in situ imaging, preventing or treating lung diseases, tumors or metastases |
| 09/04/2003 | US20030165889 Identifying and detecting virulence determinant genes of Legionella pneumophila in cells; diagnosing infections |
| 09/04/2003 | US20030165878 Novel compositions and methods in cancer associated with altered expression of MCM3AP |
| 09/04/2003 | US20030165872 Comprises nucleotide sequences coding protozoan parasite protein for diagnosis and prevention of infections; veterinary medicine; miticides; parasiticides; dog vaccine |
| 09/04/2003 | US20030165851 Novel polypetides and nucleic acids encoding same |
| 09/04/2003 | US20030165820 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 09/04/2003 | US20030165819 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 09/04/2003 | US20030165817 Diagnostic assay |
| 09/04/2003 | US20030165816 Comprises mutant hepatitis B surface antigen for detecting viral diseases; immunoassays; kidney disorders |
| 09/04/2003 | US20030165814 Screening for sensitivity to mystery swine disease virus infection by transfecting cells with CD antigens; animal husbandry |
| 09/04/2003 | US20030165809 MARKs as modifiers of the p53 pathway and methods of use |
| 09/04/2003 | US20030165807 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 09/04/2003 | US20030165543 Transgenic plant-based vaccines |
| 09/04/2003 | US20030165542 Intensifier of hematopoietic bone marrow stem cells |
| 09/04/2003 | US20030165540 Sentinel virus II |
| 09/04/2003 | US20030165539 Chimeric vaccine against tick-borne encephalitis virus |
| 09/04/2003 | US20030165538 Vaccines, biocatalyst; supplying to respiratory system, mucous membrane; modulate immunology response; fusion protein with spore overcoatings |
| 09/04/2003 | US20030165537 Vaccination against host cell-associated herpes viruses |
| 09/04/2003 | US20030165536 Veterinary medicine; vaccine containing mutant gene |
| 09/04/2003 | US20030165535 Gag protein genes; reduced sensitivity |
| 09/04/2003 | US20030165531 Flt3-ligand as a vaccine adjuvant |
| 09/04/2003 | US20030165529 Vaccine against tyrpanosomiasis |
| 09/04/2003 | US20030165528 Streptococcus pyogenes antigens |
| 09/04/2003 | US20030165527 Streptococcus vaccine; veterinary medicine |
| 09/04/2003 | US20030165526 Genetic engineering; induce immunology; insertion lymphocyte epitope into fish fusion protein |
| 09/04/2003 | US20030165525 TB diagnostic based on antigens from M. tuberculosis |
| 09/04/2003 | US20030165524 Immunization of dairy cattle with GapC protein against Streptococcus infection |
| 09/04/2003 | US20030165523 Prevent infections from mites |
| 09/04/2003 | US20030165521 Influenza vaccine |
| 09/04/2003 | US20030165520 Attenuated forms of bovine viral diarrhea virus |
| 09/04/2003 | US20030165519 Administering complex of protein taken from original tumor |
| 09/04/2003 | US20030165518 Mixed haptenized tumor cells and extracts and methods of treating or screening for cancer |
| 09/04/2003 | US20030165517 Administering immunotherapy; induction immunology response |
| 09/04/2003 | US20030165516 Cytotoxic lumphocyte response; genetic engineering mutants |
| 09/04/2003 | US20030165515 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
| 09/04/2003 | US20030165514 Modulate immunology response |
| 09/04/2003 | US20030165513 Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| 09/04/2003 | US20030165512 Composition of antigen and glycolipid adjuvant for sublingual administration |
| 09/04/2003 | US20030165511 Protein-virus Complex; culture product; viricides |
| 09/04/2003 | US20030165507 Postexposure prophylaxis therapy |
| 09/04/2003 | US20030165506 Novel alpha-catenin expressed in heart and testis |
| 09/04/2003 | US20030165505 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
| 09/04/2003 | US20030165504 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/04/2003 | US20030165503 Vaccine for the treatment of atherosclerosis |
| 09/04/2003 | US20030165502 Administering insulin-like growth factor binding proteins; antitumor, anticancer agent |
| 09/04/2003 | US20030165501 Protein antagonist; insulin resistance; muscle disorders |
| 09/04/2003 | US20030165499 Compositions and methods for treating psoriasis |
| 09/04/2003 | US20030165497 RRP sequences and knockout mice and uses thereof |
| 09/04/2003 | US20030165496 Alzheimer's disease |
| 09/04/2003 | US20030165494 Rheumatic diseases; anticholesterol agents; cardiovascular disorders; multiple sclerosis |
| 09/04/2003 | US20030165483 Immobilization; contacting disease cells; cellular tumor vaccine |
| 09/04/2003 | US20030165478 Stabilized synthetic immunogen delivery system |
| 09/04/2003 | US20030165477 Poxvirus with targeted infection specificity |
| 09/04/2003 | US20030165476 Macroaggregated protein conjugates as oral genetic immunization delivery agents |
| 09/04/2003 | US20030165465 Treatment of neoplasms with viruses |
| 09/04/2003 | US20030165460 Proteins which control cell differentiation; immunology response; antiinflammatory agents; wound healing agents |
| 09/04/2003 | US20030165459 Binding to tumor necrosis factor |
| 09/04/2003 | CA2743750A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from respiratory syncytial virus |
| 09/04/2003 | CA2513190A1 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors |
| 09/04/2003 | CA2483556A1 Hsp70-derived peptides an uses thereof in the diagnosis and treatment of autoimmune diseases |
| 09/04/2003 | CA2477417A1 Methods and products based on oligomerization of stress proteins |
| 09/04/2003 | CA2477409A1 Process for the preparation of hypoallergenic major birch pollen allergen rbet v 1 |
| 09/04/2003 | CA2477408A1 An obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity |
| 09/04/2003 | CA2477309A1 Screening process |
| 09/04/2003 | CA2477249A1 Novel type-1 cytokine receptor glm-r |
| 09/04/2003 | CA2477235A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 09/04/2003 | CA2477234A1 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
| 09/04/2003 | CA2477178A1 Administration of agents for the treatment of inflammation |
| 09/04/2003 | CA2477170A1 Compositions and methods for eliciting an immune response to gram-negative bacterial infections |
| 09/04/2003 | CA2477094A1 Ricin vaccine and methods of making and using thereof |
| 09/04/2003 | CA2477037A1 Recombinant negative strand virus rna expression systems and vaccines |